Marimed Stock Current Liabilities

MRMD Stock  USD 0.14  0.01  6.67%   
Marimed fundamentals help investors to digest information that contributes to Marimed's financial success or failures. It also enables traders to predict the movement of Marimed OTC Stock. The fundamental analysis module provides a way to measure Marimed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Marimed otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Marimed OTC Stock Current Liabilities Analysis

Marimed's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

 = 

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis

Current Marimed Current Liabilities

    
  3.16 M  
Most of Marimed's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Marimed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition

In accordance with the recently published financial statements, Marimed has a Current Liabilities of 3.16 M. This is 99.82% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current liabilities for all United States stocks is 99.96% higher than that of the company.

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Marimed Fundamentals

About Marimed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Marimed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Marimed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Marimed based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Marimed OTC Stock

Marimed financial ratios help investors to determine whether Marimed OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marimed with respect to the benefits of owning Marimed security.